drugset / Trial / NCT03058744
Topically Applied IDP-118 Lotion and HP Monad Lotion in Subjects With Moderate to Severe Plaque Psoriasis
RandomizedParallel-groupOpen-labelTreatment
Summary
Suppression Potential of Topically Applied IDP-118 Lotion and HP Monad Lotion in Subjects with Moderate to Severe Plaque Psoriasis.
Timeline
- Start
- 2015-04
- Primary completion
- 2016-12
- Completion
- 2017-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HP Monad | Unknown | — | — |
| Subject | IDP-118 | Unknown | — | — |
| Comparator | Tazarotene | Small molecule | — | — |
| Comparator | halobetasol propionate | Small molecule | — | — |